Page last updated: 2024-08-23

mefloquine and Behavior Disorders

mefloquine has been researched along with Behavior Disorders in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's15 (46.88)18.2507
2000's14 (43.75)29.6817
2010's3 (9.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Block, J; Nevin, RL; Ritchie, EC1
Grabias, B; Kumar, S1
Chelo, D; Djoukoue, F; Frey, SG; Hatz, C; Kinkela, MN; Tietche, F; Weber, P1
Odenholt, I; Petersson, H; Rietz, G1
Baran, B; Gazdag, G; Murai, Z; Szily, E; Tolna, J1
Pepplinkhuizen, L; Stricker, BH; Sturkenboom, MC; van Riemsdijk, MM1
Strauss, BA; Tepper, ML1
Corbeil, TE; Goldfinger, WE; Hansen, CJ; Reed, RJ; Ryan, MA; Smith, B; Smith, TC; Spooner, CN; Wang, LZ; Wells, TS1
Alisky, JM; Chertkova, EL; Iczkowski, KA1
Aarnoudse, AL; Dieleman, J; Ligthelm, RJ; Molokhia, M; Overbosch, D; Stricker, BH; van der Heiden, IP; van Riemsdijk, MM; van Schaik, RH1
Croft, AM1
Black, J1
Lench, P1
Bazin, N; Bisaro, F; Bourée, P; Feline, A; Hennequin, C1
Bernardo, M; Parellada, E1
Barrett, PJ; Bradley, DJ; Clarke, PD; Emmins, PD1
Behrens, RH; Corbett, EL; Doherty, JP1
Phillips, M1
Dollow, S1
Warner, J1
Ellis-Pegler, RB; Ingram, RJ1
Bygbjerg, IC; Gøtzsche, PC; Rønn, AM; Rønne-Rasmussen, J1
Jensen, JJ1
Bygbjerg, IC; Rønn, AM1
Beny, A; Potasman, I; Seligmann, H1
Abell, L1
Javorsky, DJ; Keitner, GI; Parmentier, AH; Tremont, G1
Eichenlaub, D; Fleischer, K; Held, T; Kern, W; Pohle, HD; Trautmann, M; Weber, G; Weinke, T1
Held, T; Mravak, S; Trautmann, M; Weinke, T1

Reviews

2 review(s) available for mefloquine and Behavior Disorders

ArticleYear
Adverse neuropsychiatric effects of antimalarial drugs.
    Expert opinion on drug safety, 2016, Volume: 15, Issue:7

    Topics: Antimalarials; Humans; Malaria; Mefloquine; Mental Disorders; Neurotoxicity Syndromes

2016
A lesson learnt: the rise and fall of Lariam and Halfan.
    Journal of the Royal Society of Medicine, 2007, Volume: 100, Issue:4

    Topics: Antimalarials; Drug Industry; Financing, Government; Forecasting; Humans; Interprofessional Relations; Malaria; Mefloquine; Mental Disorders; Military Personnel; Phenanthrenes; Technology, Pharmaceutical; United States; United States Food and Drug Administration

2007

Trials

2 trial(s) available for mefloquine and Behavior Disorders

ArticleYear
Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
    Malaria journal, 2010, Oct-21, Volume: 9

    Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Plasmodium falciparum

2010
[Clinical experiences with mefloquine in tropical malaria--a prospective study].
    Immunitat und Infektion, 1991, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Africa, Western; Animals; Female; Germany; Humans; Madagascar; Malaria; Male; Mefloquine; Mental Disorders; Nausea; Nervous System Diseases; Plasmodium falciparum; Prospective Studies; Travel; Uganda; Vomiting

1991

Other Studies

28 other study(ies) available for mefloquine and Behavior Disorders

ArticleYear
Psychiatric side effects of mefloquine: applications to forensic psychiatry.
    The journal of the American Academy of Psychiatry and the Law, 2013, Volume: 41, Issue:2

    Topics: Adverse Drug Reaction Reporting Systems; Aggression; Antimalarials; Comorbidity; Contraindications; Diagnosis, Differential; Drug Labeling; Expert Testimony; Humans; Insanity Defense; Liability, Legal; Mefloquine; Mental Disorders; Neuropsychological Tests; Psychoses, Substance-Induced; Suicide; Violence

2013
[Many travellers suffer of side-effects of malaria prophylaxis].
    Lakartidningen, 2002, Jun-27, Volume: 99, Issue:26-27

    Topics: Antimalarials; Chloroquine; Drug Eruptions; Gastrointestinal Diseases; Humans; Malaria; Mefloquine; Mental Disorders; Proguanil; Surveys and Questionnaires; Travel

2002
FDA requires warnings on anti-malaria drug Lariam.
    Consumer reports, 2004, Volume: 69, Issue:1

    Topics: Antimalarials; Consumer Product Safety; Drug Labeling; Humans; Mefloquine; Mental Disorders; United States; United States Food and Drug Administration

2004
[Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
    Orvosi hetilap, 2005, Jan-16, Volume: 146, Issue:3

    Topics: Adult; Antimalarials; Depression; Female; Humans; Malaria; Male; Mefloquine; Mental Disorders; Middle Aged; Panic Disorder; Primary Prevention; Psychoses, Substance-Induced; Retrospective Studies; Travel

2005
Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:2

    Topics: Adult; Affective Disorders, Psychotic; Antimalarials; Case-Control Studies; Cohort Studies; Female; Humans; Insurance; Insurance, Health, Reimbursement; International Agencies; International Cooperation; Malaria; Male; Mefloquine; Mental Disorders; Middle Aged; Netherlands; Odds Ratio; Risk Factors; Sex Factors; Surveys and Questionnaires; Travel

2005
Methodological concerns regarding the relation between mefloquine and serious psychiatric events in females.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1

    Topics: Antimalarials; Case-Control Studies; Female; Humans; Malaria; Male; Mefloquine; Mental Disorders; Mental Recall; Research Design; Sex Characteristics; Sex Distribution; Sex Factors; Travel

2006
Mefloquine use and hospitalizations among US service members, 2002-2004.
    The American journal of tropical medicine and hygiene, 2006, Volume: 74, Issue:5

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Cohort Studies; Europe; Female; Hospitalization; Hospitals, Military; Humans; Japan; Malaria; Male; Mefloquine; Mental Disorders; Military Personnel; Proportional Hazards Models; Severity of Illness Index; Travel; United States

2006
Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis.
    Medical hypotheses, 2006, Volume: 67, Issue:5

    Topics: Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chloroquine; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Loperamide; Mefloquine; Mental Disorders; Psychotic Disorders

2006
MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.
    Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:4

    Topics: Adult; Aged; Antimalarials; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Confidence Intervals; Cysteine; Female; Gene Frequency; Genes, MDR; Glycine; Haplotypes; Humans; Male; Mefloquine; Mental Disorders; Middle Aged; Nervous System Diseases; Odds Ratio; Organic Anion Transporters; Polymorphism, Genetic; Reference Values; Threonine; Travel; White People

2006
Lariam and Halfan.
    Journal of the Royal Society of Medicine, 2007, Volume: 100, Issue:8

    Topics: Antimalarials; Humans; Malaria; Mefloquine; Mental Disorders; Phenanthrenes; Randomized Controlled Trials as Topic; Time Factors

2007
Malaria prophylaxis. Psychological problems after mefloquine and chloroquine.
    BMJ (Clinical research ed.), 1995, Jul-15, Volume: 311, Issue:6998

    Topics: Chloroquine; Humans; Malaria; Mefloquine; Mental Disorders

1995
Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine.
    Archives of internal medicine, 1994, Oct-24, Volume: 154, Issue:20

    Topics: Adult; Humans; Male; Mefloquine; Mental Disorders; Middle Aged

1994
[Mefloquine and severe psychiatric disorder].
    Medicina clinica, 1994, Apr-23, Volume: 102, Issue:15

    Topics: Humans; Mefloquine; Mental Disorders

1994
Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
    BMJ (Clinical research ed.), 1996, Aug-31, Volume: 313, Issue:7056

    Topics: Adult; Antimalarials; Chloroquine; Drug Therapy, Combination; Female; Health Surveys; Hospitalization; Humans; Malaria; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Proguanil; Retrospective Studies; Travel; Treatment Refusal; United Kingdom

1996
Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings.
    BMJ (Clinical research ed.), 1996, Dec-14, Volume: 313, Issue:7071

    Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Humans; Mefloquine; Mental Disorders; Proguanil; Travel

1996
Adverse events associated with mefloquine. Women may be more susceptible to adverse events.
    BMJ (Clinical research ed.), 1996, Dec-14, Volume: 313, Issue:7071

    Topics: Antimalarials; Doxycycline; Drug Combinations; Female; Humans; Male; Mefloquine; Mental Disorders; Sex Characteristics

1996
Adverse events associated with mefloquine. Risk-benefit ratio must be taken into account.
    BMJ (Clinical research ed.), 1996, Dec-14, Volume: 313, Issue:7071

    Topics: Antimalarials; Chloroquine; Drug Combinations; Humans; Mefloquine; Mental Disorders; Proguanil; Risk Factors; Travel

1996
Adverse events associated with mefloquine. Advice to warn patients about rare side effects overturns accepted practice.
    BMJ (Clinical research ed.), 1996, Dec-14, Volume: 313, Issue:7071

    Topics: Antimalarials; Duty to Warn; Humans; Mefloquine; Mental Disorders

1996
Malaria, mefloquine and the mind.
    The New Zealand medical journal, 1997, Apr-25, Volume: 110, Issue:1042

    Topics: Antimalarials; Central Nervous System Diseases; Female; Humans; Malaria; Male; Mefloquine; Mental Disorders; Travel

1997
Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.
    Tropical medicine & international health : TM & IH, 1998, Volume: 3, Issue:2

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Bias; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Prevalence; Prospective Studies; Research Design; Retrospective Studies; Surveys and Questionnaires

1998
[Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
    Ugeskrift for laeger, 1998, Apr-13, Volume: 160, Issue:16

    Topics: Adult; Antimalarials; Anxiety Disorders; Female; Humans; Male; Mefloquine; Mental Disorders; Middle Aged; Nervous System Diseases; Sleep Wake Disorders

1998
[Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
    Ugeskrift for laeger, 1999, Mar-08, Volume: 161, Issue:10

    Topics: Adult; Antimalarials; Anxiety Disorders; Brain Diseases; Female; Headache; Humans; Mefloquine; Mental Disorders; Neurologic Examination; Time Factors; Vision Disorders

1999
Neuropsychiatric problems in 2,500 long-term young travelers to the tropics.
    Journal of travel medicine, 2000, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Africa; Antimalarials; Asia, Southeastern; Cohort Studies; Female; Humans; Israel; Malaria; Male; Mefloquine; Mental Disorders; Middle Aged; Prevalence; Sex Factors; South America; Substance-Related Disorders; Surveys and Questionnaires; Travel; Tropical Climate

2000
Health advice for travelers.
    The New England journal of medicine, 2000, Oct-05, Volume: 343, Issue:14

    Topics: Antimalarials; Doxycycline; Humans; Malaria; Mefloquine; Mental Disorders; Travel

2000
Cognitive and neuropsychiatric side effects of mefloquine.
    The Journal of neuropsychiatry and clinical neurosciences, 2001,Spring, Volume: 13, Issue:2

    Topics: Antimalarials; Cognition Disorders; Female; Humans; Malaria; Mefloquine; Mental Disorders; Middle Aged

2001
Lariam's legacy.
    Consumer reports, 2002, Volume: 67, Issue:3

    Topics: Antimalarials; Consumer Product Safety; Doxycycline; Drug Costs; Humans; Malaria; Mefloquine; Mental Disorders; Naphthoquinones; Proguanil; United States; United States Food and Drug Administration

2002
Malaria, mefloquine, madness, and mosquito nets.
    JAMA, 1991, Jun-05, Volume: 265, Issue:21

    Topics: Animals; Culicidae; Humans; Insect Bites and Stings; Malaria; Mefloquine; Mental Disorders

1991
Neuropsychiatric side effects after the use of mefloquine.
    The American journal of tropical medicine and hygiene, 1991, Volume: 45, Issue:1

    Topics: Adult; Africa; Anxiety Disorders; Female; Germany; Humans; Male; Mefloquine; Mental Disorders; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Travel

1991